Back to results
US 6,875,856 B2Granted
Recombinant infectious laryngotracheitis virus and uses thereof
AssigneeSyntro Corporation
InventorsMartha A. Wild, Mark D. Cochran
Life of this patent
Estimating the term…
Abstract
Recombinant, attenuated infectious laryngotracheitis viruses containing a deletion or deletions in a glycoprotein gene are provided. Also provided are glycoprotein genes, gD, gI, gG and gE as well as other viral genes.
Claims11
An isolated nucleic acid molecule encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:7.
A recombinant DNA molecule comprising DNA encoding the amino acid sequence of SEQ ID NO:7.
A recombinant DNA molecule comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:7, wherein the nucleotide sequence is comprised by SEQ ID NO:1.
Dependencies are inferred from the claim text.